Close

Research Grade (RG) CAR-T mRNA Manufacturing Service

Online Inquiry

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

CAR-T therapy has emerged as a groundbreaking approach in the immunotherapy landscape. Given the complexity and specificity of CAR-T therapy, the production of high-quality materials such as in vitro transcribed RNA (IVT RNA) is crucial. IVT RNA plays an essential role in delivering genetic information into T cells, facilitating the expression of CARs. At Creative Biolabs, we are committed to providing top-tier IVT RNA manufacturing services specifically optimized for CAR-T applications. Our advanced platform ensures precision and efficiency, supporting researchers and clinicians in the development and deployment of cutting-edge CAR-T therapies.

RG mRNA Manufacturing Service

At Creative Biolabs, our IVT RNA platform is meticulously designed to meet the diverse needs of researchers and clinicians in developing of CAR-T therapy. This platform integrates state-of-the-art technologies and stringent quality control measures to ensure the production of high-fidelity mRNA transcripts, which are crucial for effective CAR-T cell engineering. Utilizing a comprehensive IVT RNA platform, our experts proudly provide high-quality mRNA tailored for research purposes, ensuring that the initial stages of CAR-T and other advanced therapies are founded on reliable and effective mRNA constructs. By employing our RG mRNA manufacturing platform, researchers can confidently advance their CAR-T studies, armed with the assurance that their mRNA constructs are of the highest quality.

One-stop IVT RNA and LNP Manufacturing

Fig.1 Our services. (Creative Biolabs original)

Highlights

  • Custom Design and Synthesis: We offer bespoke mRNA synthesis services that accommodate unique research needs, from gene sequence design to the final RNA product. Our clients can specify gene sequence design, choice of capping methods, and customizable poly(A) tail length to optimize the performance of their RNA.
  • High Purity and Yield: Our process ensures high yields of mRNA with exceptional purity, minimizing contaminants that could potentially interfere with downstream applications.
  • Scalability: Whether you require small-scale mRNA for preliminary testing or larger batches for extensive research, our platform is equipped to scale production accordingly.
  • Comprehensive Quality Control: Each batch of mRNA undergoes rigorous testing to verify its integrity, including sequencing and in vitro translation assessments, guaranteeing that you receive a product that performs reliably in your experiments.

Working with Creative Biolabs

At Creative Biolabs, we are committed to advancing the field of CAR-T therapy through our specialized IVT RNA and LNP manufacturing services. Our robust RG mRNA manufacturing platform combines scalability, high purity, customization, advanced quality control, and efficient delivery systems to meet the diverse needs of CAR-T researchers. By partnering with us, you gain access to cutting-edge technologies and expert support, empowering you to drive innovation and make significant strides in the fight against cancer.

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.